6 completed, 4 unknown, 1 not yet recruiting. 5 Phase 4, 3 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Unknown 4, Completed 1 |
| Not applicable | 3 | Completed 2, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Glycerylphosphorylcholine: new trials by email Literature Review of Glycerylphosphorylcholine trials Research Report on Glycerylphosphorylcholine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acute Effects of Alpha-glycerylphosphorylcholine (A-GPC) on Lower Body Muscular Performance. L-Alpha glycerylphosphorylcholine, Microcrystalline Cellulose - Healthy Adult Participants | Not applicable | Not yet recruiting | Northern Illinois University | 20 | 2026-03-16 | 2026-02-09 |
| Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints choline alphoscerate, Placebo - Major Depression | Not applicable | Completed | Samsung Medical Center | 120 | 2022-08-19 | 2026-07-27 |
| Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease Choline Alfoscerate 400mg, Placebo - Alzheimer Disease | Phase 4 | Unknown | Daewoong Bio Inc. | 630 | 2022-01-20 | 2024-03-21 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Choline Alfoscerate, Placebo - Mild Cognitive Impairment | Phase 4 | Unknown | Chong Kun Dang Pharmaceutical | 418 | 2021-09-30 | 2021-09-20 |
| A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients Choline Alfoscerate 400mg, Placebo of Choline Alfoscerate 400mg - Vascular Cognitive Impairment | Phase 4 | Unknown | Chong Kun Dang Pharmaceutical | 418 | 2021-09-01 | 2021-09-20 |
| Choline Alphoscerate-Nimodipine in Vascular Cognitive Impairment Choline alphoscerate, Placebo - Vascular Cognitive Impairment | Phase 2 | Completed | Azienda Ospedaliero-Universitaria Careggi | 62 | 2017-05-02 | 2020-01-13 |
| Alpha-GPC and Physical and Cognitive Performances in Volleyball Players. Placebo, Experimental - Athletic Performance | Not applicable | Completed | Université de Montréal | 28 | 2016-08-29 | 2017-04-21 |
| The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes Choline alfoscerate, Placebo - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Seoul National University Bundang Hospital | 36 | 2016-03-10 | 2019-10-08 |
| A Clinical Trial for an Evaluation of Choline Alfoscerate and Donepezil for Cognitive Improvements of Patients With Cerebrovascular Injury in Alzheimer Patients Choline alfoscerate, Placebo - Alzheimer Disease | Phase 4 | Unknown | Daewoong Pharmaceutical Co. LTD. | 128 | 2015-07-01 | 2016-11-02 |
| Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke. citicoline, L-Alpha glycerylphosphorylcholine, cerebrolysin - Stroke | Phase 3 | Completed | Clinical Institute of the Brain, Russia | 30 | 2011-01-01 | 2011-12-23 |
| The Efficacy of Gliatiline® on Post-stroke Patients With Vascular Cognitive Impairment no Dementia choline alfoscerate, placebo (for choline alphoscerate) - Cognitive Impairment, Stroke | Phase 4 | Completed | Seoul National University Hospital | 222 | 2010-11-01 | 2013-10-14 |
Alzheimer Disease (2) · Cognitive Dysfunction (2) · Stroke (2) · Depressive Disorder, Major (1) · Diabetes Mellitus, Type 2 (1) · Ischemic Stroke (1)
Chong Kun Dang Pharmaceutical (2) · Azienda Ospedaliero-Universitaria Careggi (1) · Clinical Institute of the Brain, Russia (1) · Daewoong Bio Inc. (1) · Daewoong Pharmaceutical Co. LTD. (1) · Northern Illinois University (1) · Samsung Medical Center (1) · Seoul National University Bundang Hospital (1) · Seoul National University Hospital (1) · Université de Montréal (1)
South Korea (7) · Canada (1) · Italy (1) · Russia (1) · United States (1)
Clayton Camic, PHD (1) · JaeHong Lee, MD (1) · Jonathan Tremblay, Ph.D (1) · Raynald Bergeron, Ph.D (1) · Samuel St-Arnaud, B.Sc (1) · Sun U Kwon, MD, PhD (1)
2015 (1)